Breast cancer surgeon is struck off because of risk to patients (vol 343, d7249, 2011)

被引:0
|
作者
Dyer, Clare
机构
来源
BRITISH MEDICAL JOURNAL | 2011年 / 343卷
关键词
D O I
10.1136/bmj.d8285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [41] The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
    L. K. Teh
    N. I. Mohamed
    M. Z. Salleh
    M. Rohaizak
    N. S. Shahrun
    J. J. Saladina
    J. K. S. Shia
    H. Roslan
    S. Sood
    T. S. Rajoo
    S. P. Muniandy
    G. Henry
    H. A. Ngow
    K. T. Hla U
    J. Din
    The AAPS Journal, 2012, 14 : 52 - 59
  • [42] Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence
    Ardavanis, A
    Scorilas, A
    Loukeri, A
    Gerakini, F
    Pissakas, G
    Missitzis, I
    Apostolikas, N
    Yiotis, I
    ANTICANCER RESEARCH, 1998, 18 (4B) : 2885 - 2890
  • [43] Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India
    Sofi, Nighat Y.
    Jain, Monika
    Kapil, Umesh
    Seenu, Vuthaluru
    Kamal, Vineet Kumar
    Pandey, Ravinder Mohan
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 175 : 55 - 59
  • [44] The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
    Teh, L. K.
    Mohamed, N. I.
    Salleh, M. Z.
    Rohaizak, M.
    Shahrun, N. S.
    Saladina, J. J.
    Shia, J. K. S.
    Roslan, H.
    Sood, S.
    Rajoo, T. S.
    Muniandy, S. P.
    Henry, G.
    Ngow, H. A.
    Hla U, K. T.
    Din, J.
    AAPS JOURNAL, 2012, 14 (01): : 52 - 59
  • [46] CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients (vol 104, pg 452, 2012)
    Rae, James M.
    Hayes, Daniel F.
    Cuzick, Jack
    Sestak, Ivana
    Dowsett, Mitch
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (22) : 1772 - 1772
  • [47] Guideline for the Prevention and Early detection of Breast and Ovarian cancer in High-risk patients, especially in Women from HBOC (Hereditary Breast and Ovarian Cancer) families vol 124, pg 334, 2012
    Singer, Christian F.
    Tea, Muy-Kheng
    Pristauz, Gunda
    Hubalek, Michael
    Rappaport, Christine
    Riedl, Christopher
    Helbich, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (19-20) : 735 - 735
  • [48] Evalution of effect of Vitamin D levels and tumor Vitamin D receptor status as a risk factor and marker for therapeutic response Indian breast cancer patients.
    Singh, Kul Ranjan
    Sonkar, Abhinav Arun
    Saxena, Prarthana
    Kushwaha, Jitendra Kumar
    Agarwal, Akshay Anand
    Husain, Nuzhat
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients (vol 12, pg 1, 2020)
    Xie, N.
    Tian, C.
    Wu, H.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13